Berenberg Initiates Coverage On Alpine Immune Sciences with Buy Rating, Announces Price Target of $18
Portfolio Pulse from Benzinga Newsdesk
Berenberg analyst Andy Chen has initiated coverage on Alpine Immune Sciences (NASDAQ:ALPN) with a Buy rating and a price target of $18.
October 18, 2023 | 9:08 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Alpine Immune Sciences has been initiated with a Buy rating by Berenberg, with a price target of $18.
The initiation of coverage by Berenberg with a Buy rating and a price target of $18 indicates a positive outlook for Alpine Immune Sciences. This could potentially attract investors and drive the stock price up in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100